We demonstrated the effect of ADORA1 on T cells, showing that inhibition of ADORA1 in the shADORA1 group increased the recruitment of CD4+ T and CD8+ T cells to gliomas compared to the control group. This evidence concerns the gene CD4 and central nervous system cancer.